XML 114 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Associated companies (Tables)
 12 Months Ended
Dec. 31, 2022
Statement [line items]  
Schedule disclosing information related to associates
Net income statement effect
Other comprehensive income effect 1
Total comprehensive income effect
(USD millions)
2022
2021
2020
2022
2021
2020
2022
2021
2020
Roche Holding AG, Switzerland
15 341
677
46
-56
15 387
621
Others
-9
-2
-4
-9
-2
-4
Associated companies
-9
15 339
673
46
-56
-9
15 385
617
 1  In 2021, Novartis share of other comprehensive income recognized by associated companies, net of taxes of USD 3 million was recycled into the consolidated income statement as a result of the divestment of the investment in Roche Holding AG. No Novartis share of other comprehensive income recognized by associated companies was recycled to the consolidated income statement in 2022 and 2020.
Roche Holding AG, Switzerland  
Statement [line items]  
Schedule disclosing information related to associates, net income effect
(USD millions)
2021
2020
Novartis share of Roche's estimated current-year consolidated net income
815
913
Prior-year adjustment
40
-64
Amortization of fair value adjustments relating to intangible assets, net of taxes of 2021: USD 10 million; 2020: USD 26 million
-70
-172
Gain on divestment of the investment in Roche  1
14 556
Net income effect
15 341
677
 1  The gain on divestment of the investment in Roche includes the recycling of currency translation effects (see Note 8.1) and other comprehensive income effects totaling USD 3.2 billion.